Endocrine Abstracts

Objectives: Analysis of the work of the diabetic foot office (DFO), the number of amputations and the causes that led to this complication of diabetic foot syndrome (DFS) underlies the development of preventive measures that help to reduce the level of disability and lethality, which is an urgent and socially significant medical problem.

Objective: To study the indicators characterizing the provision of medical care to patients with diabetes and lower limb lesions in Minsk from 2019 to 2023 and the relationship of these indicators with the developed regulatory documentation determining the optimal routing of this group of patients.

Materials and Methods: Annual reports were analyzed according to the database of the "Diabetic Foot" department of the health care institution "Minsk City Clinical Endocrinology Center" (MCCEC). Indicators for 2019-2023 of adult patients with diabetes were evaluated.

Results: After implementation of a regulatory document defining the sequence of patient referral and routing the number of patients per year admitted to the MCCEC increased from 6883 in 2019 to 7633 in 2023. The percentage of patients initially admitted with DFS in 2019 was 19% and increased to 35.7% in 2023. There is a decrease in high amputations: at the hip level from 17.9% in 2019 to 15.2% in 2023, at the tibial level from 10.5% in 2019 to 8.9% in 2023. There is a gradual increase in the percentage of finger-level amputations from 61% in 2019 to 67% in 2023.

Conclusions: The analysis of statistics of specialized care for patients with DFS for 5 years has shown that the development of thematic documents and optimization of patient routing significantly increase the capacity of specialized care, which leads to early detection of patients with DFS, and as a result - a decrease in the frequency of high amputations, which may reflect the improvement of the quality of patient management by endocrinologists and surgeons at the outpatient stage, and increase the effectiveness of prevention of lower limb lesions.